Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID DTD0178 Transporter Info
Gene Name SLC25A19
Transporter Name Mitochondrial thiamine pyrophosphate carrier
Gene ID
60386
UniProt ID
Q9HC21
Post-Translational Modification of This DT
Overview of SLC25A19 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-Phosphorylation X-Succinylation X-Ubiquitination X: Amino Acid

Acetylation

  Lysine

           2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

 Have the potential to influence SLC25A19 [1]

Role of PTM

 Potential impacts

Modified Residue

 Lysine

Modified Location

 241

Experimental Method

 Co-Immunoprecipitation

Detailed Description

 Acetylation at SLC25A19 Lysine 241 has the potential to affect its expression or activity.

  PTM Phenomenon 2

 Have the potential to influence SLC25A19 [2]

Role of PTM

 Potential impacts

Modified Residue

 Lysine

Modified Location

 263

Experimental Method

 Co-Immunoprecipitation

Detailed Description

 Acetylation at SLC25A19 Lysine 263 has the potential to affect its expression or activity.

Phosphorylation

  Serine

           4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

 Have the potential to influence SLC25A19 [3]

Role of PTM

 Potential impacts

Modified Residue

 Serine

Modified Location

 23

Experimental Method

 Co-Immunoprecipitation

Detailed Description

 Phosphorylation at SLC25A19 Serine 23 has the potential to affect its expression or activity.

  PTM Phenomenon 2

 Have the potential to influence SLC25A19 [3]

Role of PTM

 Potential impacts

Modified Residue

 Serine

Modified Location

 25

Experimental Method

 Co-Immunoprecipitation

Detailed Description

 Phosphorylation at SLC25A19 Serine 25 has the potential to affect its expression or activity.

  PTM Phenomenon 3

 Have the potential to influence SLC25A19 [4] , [5]

Role of PTM

 Potential impacts

Modified Residue

 Serine

Modified Location

 51

Experimental Method

 Co-Immunoprecipitation

Detailed Description

 Phosphorylation at SLC25A19 Serine 51 has the potential to affect its expression or activity.

  PTM Phenomenon 4

 Have the potential to influence SLC25A19 [6]

Role of PTM

 Potential impacts

Modified Residue

 Serine

Modified Location

 288

Experimental Method

 Co-Immunoprecipitation

Detailed Description

 Phosphorylation at SLC25A19 Serine 288 has the potential to affect its expression or activity.

  Tyrosine

           1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

 Have the potential to influence SLC25A19 [7]

Role of PTM

 Potential impacts

Modified Residue

 Tyrosine

Modified Location

 4

Experimental Method

 Co-Immunoprecipitation

Detailed Description

 Phosphorylation at SLC25A19 Tyrosine 4 has the potential to affect its expression or activity.

Succinylation

  Lysine

           1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

 Have the potential to influence SLC25A19 [8]

Role of PTM

 Potential impacts

Modified Residue

 Lysine

Modified Location

 275

Experimental Method

 Co-Immunoprecipitation

Detailed Description

 Succinylation at SLC25A19 Lysine 275 has the potential to affect its expression or activity.

Ubiquitination

  Glutamine

           1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

 Have the potential to influence SLC25A19 [9]

Role of PTM

 Potential impacts

Modified Residue

 Glutamine

Modified Location

 218

Experimental Method

 Co-Immunoprecipitation

Detailed Description

 Ubiquitination at SLC25A19 Glutamine 218 has the potential to affect its expression or activity.

  Lysine

           2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

 Have the potential to influence SLC25A19 [9]

Role of PTM

 Potential impacts

Modified Residue

 Lysine

Modified Location

 153

Experimental Method

 Co-Immunoprecipitation

Detailed Description

 Ubiquitination at SLC25A19 Lysine 153 has the potential to affect its expression or activity.

  PTM Phenomenon 2

 Have the potential to influence SLC25A19 [9]

Role of PTM

 Potential impacts

Modified Residue

 Lysine

Modified Location

 275

Experimental Method

 Co-Immunoprecipitation

Detailed Description

 Ubiquitination at SLC25A19 Lysine 275 has the potential to affect its expression or activity.
References
1 Insights into the lysine acetylproteome of human sperm. J Proteomics. 2014 Sep 23;109:199-211.
2 Infants at risk of sudden unexpected death. Lancet. 1979 Nov 3;2(8149):954.
3 Quantitative global phosphoproteomics of human umbilical vein endothelial cells after activation of the Rap signaling pathway. Mol Biosyst. 2013 Apr 5;9(4):732-49.
4 Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res. 2013 Jan 4;12(1):260-71.
5 UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
6 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
7 The Plk1-dependent phosphoproteome of the early mitotic spindle. Mol Cell Proteomics. 2011 Jan;10(1):M110.004457.
8 Lysine Acetylation and Succinylation in HeLa Cells and their Essential Roles in Response to UV-induced Stress. Sci Rep. 2016 Jul 25;6:30212.
9 A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.